Authors:
REYNOLDS GP
BOULTON RM
PEARSON SJ
HUDSON AL
NUTT DJ
Citation: Gp. Reynolds et al., IMIDAZOLINE BINDING-SITES IN HUNTINGTONS AND PARKINSONS-DISEASE PUTAMEN, European journal of pharmacology, 301(1-3), 1996, pp. 19-21
Citation: Gp. Reynolds, THE IMPORTANCE OF DOPAMINE D-4 RECEPTORS IN THE ACTION AND DEVELOPMENT OF ANTIPSYCHORIC AGENTS (VOL 51, PG 7, 1996), Drugs, 51(3), 1996, pp. 505-505
Citation: B. Davis et al., CHRONIC ADMINISTRATION OF ANTIPSYCHOTICS POTENTIATES DOPAMINE RELEASEINDUCED BY NMDA RECEPTOR BLOCKADE IN RAT FRONTAL-CORTEX IN-VIVO, British Journal of Pharmacology, 118, 1996, pp. 72-72
Citation: Am. Sardar et Gp. Reynolds, FRONTAL-CORTEX INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY IS INCREASED IN HIV-1-ASSOCIATED DEMENTIA, Neuroscience letters, 187(1), 1995, pp. 9-12
Authors:
RIEDERER P
GSELL W
CALZA L
FRANZEK E
JUNGKUNZ G
JELLINGER K
REYNOLDS GP
CROW T
CRUZSANCHEZ FF
BECKMANN H
Citation: P. Riederer et al., CONSENSUS ON MINIMAL CRITERIA OF CLINICAL AND NEUROPATHOLOGICAL DIAGNOSIS OF SCHIZOPHRENIA AND AFFECTIVE-DISORDERS FOR POST-MORTEM RESEARCH- REPORT FROM THE EUROPEAN DEMENTIA AND SCHIZOPHRENIA NETWORK (BIOMED-I), Journal of neural transmission, 102(3), 1995, pp. 255-264
Citation: Sj. Pearson et al., AN INVESTIGATION OF THE ACTIVITIES OF 3-HYDROXYKYNURENINASE AND KYNURENINE AMINOTRANSFERASE IN THE BRAIN IN HUNTINGTONS-DISEASE, Journal of neural transmission, 102(1), 1995, pp. 67-73
Authors:
WONG EHF
REYNOLDS GP
BONHAUS DW
HSU S
EGLEN RM
Citation: Ehf. Wong et al., CHARACTERIZATION OF [H-3]GR-113808 BINDING TO 5-HT4 RECEPTORS IN BRAIN-TISSUES FROM PATIENTS WITH NEURODEGENERATIVE DISORDERS, Behavioural brain research, 73(1-2), 1995, pp. 249-252
Authors:
REYNOLDS GP
PEARSON SJ
SARDAR AM
EGGETT CJ
Citation: Gp. Reynolds et al., EXCITATORY NEUROTOXICITY AND ITS ROLE IN NEURODEGENERATION DISEASE PROCESSES, Journal of neuropathology and experimental neurology, 54, 1995, pp. 10-11
Citation: Gp. Reynolds et Am. Sardar, NEUROTOXIC MECHANISMS AND NEUROTRANSMITTER DEFICITS IN THE BRAIN IN AIDS, Journal of neurochemistry, 65, 1995, pp. 47-47
Citation: Cj. Eggett et Gp. Reynolds, MECHANISMS INVOLVED IN THE NEUROTOXICITY OF 3-HYDROXYKYNURENINE, Journal of neurochemistry, 65, 1995, pp. 171-171
Citation: Am. Sardar et al., INCREASED CONCENTRATIONS OF THE NEUROTOXIN 3-HYDROXYKYNURENINE IN THEFRONTAL-CORTEX OF HIV-1-POSITIVE PATIENTS, Journal of neurochemistry, 64(2), 1995, pp. 932-935
Citation: Gp. Reynolds et Sl. Mason, ABSENCE OF DETECTABLE STRIATAL DOPAMINE D-4 RECEPTORS IN DRUG-TREATEDSCHIZOPHRENIA, European journal of pharmacology, 281(2), 1995, pp. 5-6
Authors:
CHESSWILLIAMS R
SHEPHERD CE
COULDWELL CJ
REYNOLDS GP
Citation: R. Chesswilliams et al., THE ACTIONS OF CLOZAPINE, CHLORPROMAZINE AND THIORIDAZINE AT THE A(1)-ADRENOCEPTORS OF THE RAT VAS-DEFERENS AND SPLEEN, British Journal of Pharmacology, 116, 1995, pp. 205-205
Authors:
REYNOLDS GP
MASON SL
MELDRUM A
DEKECZER S
PARNES H
EGLEN RM
WONG EHF
Citation: Gp. Reynolds et al., 5-HYDROXYTRYPTAMINE (5-HT)(4) RECEPTORS IN POST-MORTEM HUMAN BRAIN-TISSUE - DISTRIBUTION, PHARMACOLOGY AND EFFECTS OF NEURODEGENERATIVE DISEASES, British Journal of Pharmacology, 114(5), 1995, pp. 993-998
Citation: Gp. Reynolds et Sl. Mason, CLOZAPINE HAS ELEVATED AFFINITY FOR HUMAN FRONTAL CORTICAL DOPAMINE D2-LIKE RECEPTOR-SITES, Schizophrenia research, 11(2), 1994, pp. 113-113
Citation: Gp. Reynolds et Aj. Cutts, REGIONALLY SPECIFIC SUBCORTICAL GLUTAMATERGIC DEFICITS IN SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 122-122
Citation: Sj. Pearson et Gp. Reynolds, NEOCORTICAL NEUROTRANSMITTER MARKERS IN HUNTINGTONS-DISEASE, Journal of neural transmission, 98(3), 1994, pp. 197-207
Citation: R. Chesswilliams et al., DIFFERENTIAL REGULATION OF CARDIAC ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR BY THE SYMPATHETIC NERVOUS-SYSTEM, Journal of autonomic pharmacology, 14(1), 1994, pp. 29-36